Human Genome Research in New York
Human Genome Research (93.172) awarded $193 million to recipients in New York in 128 grants from fiscal 2021 to 2025, 8.9% of the program's national total. The Trustees of Columbia University in the City of New York received the most, $31.8 million.
- Awarded in New York$193 million
- Awards128
- Share of the program8.9%
- Rank among states3rd of 45
- National total$2.2 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 55 | $32.2 million |
| FY 2022 | 60 | $33.5 million |
| FY 2023 | 70 | $41.1 million |
| FY 2024 | 70 | $39.7 million |
| FY 2025 | 57 | $46.0 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | Colleges and universities | 31 | $31.8 million |
| Sloan-Kettering Institute for Cancer Research | Nonprofits | 13 | $31.0 million |
| New York Genome Center, Inc. | Nonprofits | 9 | $27.6 million |
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 13 | $25.4 million |
| New York University | Colleges and universities | 7 | $21.6 million |
| Weill Medical College of Cornell University | Colleges and universities | 2 | $12.6 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 7 | $12.0 million |
| Cold Spring Harbor Laboratory | Other | 15 | $8.7 million |
| The Feinstein Institutes for Medical Research | Nonprofits | 1 | $6.2 million |
| Cornell University | Colleges and universities | 7 | $5.8 million |
Open opportunities under this program
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
See all 65 on the program page
Questions people ask
How much Human Genome Research money goes to New York?
$193 million from fiscal 2021 to 2025, across 128 awards. New York ranks 3rd of 45 states and territories for this program.
Who receives Human Genome Research money in New York?
The largest recipient is The Trustees of Columbia University in the City of New York, with $31.8 million in 31 awards. Next are Sloan-Kettering Institute for Cancer Research and New York Genome Center, Inc..
Can organizations in New York apply now?
Yes, 65 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Human Genome Research in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund